BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34940345)

  • 1. Topical Allopurinol-Loaded Nanostructured Lipid Carriers: A Novel Approach for Wound Healing Management.
    Varrica C; Carvalheiro M; Faria-Silva C; Eleutério C; Sandri G; Simões S
    Bioengineering (Basel); 2021 Nov; 8(12):. PubMed ID: 34940345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: Toxicological effect of surface charge on human neuronal cells.
    Costa CP; Cunha S; Moreira JN; Silva R; Gil-Martins E; Silva V; Azevedo L; Peixoto AF; Sousa Lobo JM; Silva AC
    Int J Pharm; 2021 Sep; 607():120933. PubMed ID: 34324988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The topical administration of rhEGF-loaded nanostructured lipid carriers (rhEGF-NLC) improves healing in a porcine full-thickness excisional wound model.
    Gainza G; Bonafonte DC; Moreno B; Aguirre JJ; Gutierrez FB; Villullas S; Pedraz JL; Igartua M; Hernandez RM
    J Control Release; 2015 Jan; 197():41-7. PubMed ID: 25449803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition.
    Rapalli VK; Kaul V; Waghule T; Gorantla S; Sharma S; Roy A; Dubey SK; Singhvi G
    Eur J Pharm Sci; 2020 Sep; 152():105438. PubMed ID: 32598913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructured Lipid Carrier-Mediated Transdermal Delivery of Aceclofenac Hydrogel Present an Effective Therapeutic Approach for Inflammatory Diseases.
    Garg NK; Tandel N; Bhadada SK; Tyagi RK
    Front Pharmacol; 2021; 12():713616. PubMed ID: 34616297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.
    Cunha S; Costa CP; Loureiro JA; Alves J; Peixoto AF; Forbes B; Sousa Lobo JM; Silva AC
    Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and characterization of Nanostructured lipid carriers (NLC) and Nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil.
    Krambeck K; Silva V; Silva R; Fernandes C; Cagide F; Borges F; Santos D; Otero-Espinar F; Lobo JMS; Amaral MH
    Int J Pharm; 2021 May; 600():120444. PubMed ID: 33713760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
    Kaur N; Sharma K; Bedi N
    Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer.
    Imran M; Iqubal MK; Imtiyaz K; Saleem S; Mittal S; Rizvi MMA; Ali J; Baboota S
    Int J Pharm; 2020 Sep; 587():119705. PubMed ID: 32738456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructured Lipid Carriers Engineered as Topical Delivery of Etodolac: Optimization and Cytotoxicity Studies.
    Czajkowska-Kośnik A; Szymańska E; Czarnomysy R; Jacyna J; Markuszewski M; Basa A; Winnicka K
    Materials (Basel); 2021 Jan; 14(3):. PubMed ID: 33514018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
    Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
    Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes.
    Na YG; Huh HW; Kim MK; Byeon JJ; Han MG; Lee HK; Cho CW
    Acta Biomater; 2020 Jan; 101():507-518. PubMed ID: 31629894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured Lipid Carrier Gel Formulation of Recombinant Human Thrombomodulin Improve Diabetic Wound Healing by Topical Administration.
    Hsueh YS; Shyong YJ; Yu HC; Jheng SJ; Lin SW; Wu HL; Tsai JC
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique.
    Chen S; Liu W; Wan J; Cheng X; Gu C; Zhou H; Chen S; Zhao X; Tang Y; Yang X
    Drug Dev Ind Pharm; 2013 Jan; 39(1):20-8. PubMed ID: 23116283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gel-Dispersed Nanostructured Lipid Carriers Loading Thymol Designed for Dermal Pathologies.
    Folle C; Marqués AM; Díaz-Garrido N; Carvajal-Vidal P; Sánchez López E; Suñer-Carbó J; Halbaut L; Mallandrich M; Espina M; Badia J; Baldoma L; García ML; Calpena AC
    Int J Nanomedicine; 2024; 19():1225-1248. PubMed ID: 38348173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
    Baek JS; Pham CV; Myung CS; Cho CW
    Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
    Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
    J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
    Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LL37 loaded nanostructured lipid carriers (NLC): A new strategy for the topical treatment of chronic wounds.
    Garcia-Orue I; Gainza G; Girbau C; Alonso R; Aguirre JJ; Pedraz JL; Igartua M; Hernandez RM
    Eur J Pharm Biopharm; 2016 Nov; 108():310-316. PubMed ID: 27080206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.